Gajofatto A - Search Results

1

A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band.

Ferraro D, Franciotta D, Bedin R, Solaro C, Cocco E, Santangelo M, Immovilli P, Gajofatto A, Calabrese M, Di Filippo M, Orlandi R, Simone AM, Vitetta F, Capello E, Giunti D, Murialdo A, Frau J, Mariotto S, Gallina A, Gasperini C, Sola P; RIREMS group (Rising Italian Researchers in Multiple Sclerosis). Ferraro D, et al. Among authors: gajofatto a. J Neurol. 2017 May;264(5):973-978. doi: 10.1007/s00415-017-8480-5. Epub 2017 Apr 5. J Neurol. 2017. PMID: 28382419 Free article.

2

Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases.

Gajofatto A, Monaco S, Fiorini M, Zanusso G, Vedovello M, Rossi F, Turatti M, Benedetti MD. Gajofatto A, et al. Arch Neurol. 2010 Jun;67(6):724-30. doi: 10.1001/archneurol.2010.107. Arch Neurol. 2010. PMID: 20558391

3

HCV-related nervous system disorders.

Monaco S, Ferrari S, Gajofatto A, Zanusso G, Mariotto S. Monaco S, et al. Among authors: gajofatto a. Clin Dev Immunol. 2012;2012:236148. doi: 10.1155/2012/236148. Epub 2012 Jul 30. Clin Dev Immunol. 2012. PMID: 22899946 Free PMC article. Review.

4

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

Gajofatto A, Bongianni M, Zanusso G, Bianchi MR, Turatti M, Benedetti MD, Monaco S. Gajofatto A, et al. Acta Neurol Scand. 2013 Nov;128(5):336-44. doi: 10.1111/ane.12123. Epub 2013 Apr 1. Acta Neurol Scand. 2013. PMID: 23550839

5

Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.

Gajofatto A, Calabrese M, Benedetti MD, Monaco S. Gajofatto A, et al. Dis Markers. 2013;35(6):687-99. doi: 10.1155/2013/484959. Epub 2013 Nov 10. Dis Markers. 2013. PMID: 24324285 Free PMC article. Review.

6

Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study.

Gajofatto A, Bianchi MR, Deotto L, Benedetti MD. Gajofatto A, et al. Eur Neurol. 2014;72(3-4):173-80. doi: 10.1159/000361044. Epub 2014 Sep 6. Eur Neurol. 2014. PMID: 25226868

7

Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy.

Calabrese M, Gajofatto A, Benedetti MD. Calabrese M, et al. Among authors: gajofatto a. Expert Rev Neurother. 2014 Dec;14(12):1417-28. doi: 10.1586/14737175.2014.979794. Epub 2014 Nov 13. Expert Rev Neurother. 2014. PMID: 25391525 Review.

8

Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy.

Calabrese M, Gajofatto A, Gobbin F, Turri G, Richelli S, Matinella A, Oliboni ES, Benedetti MD, Monaco S. Calabrese M, et al. Among authors: gajofatto a. Mult Scler. 2015 Apr;21(5):580-9. doi: 10.1177/1352458514542363. Epub 2014 Nov 28. Mult Scler. 2015. PMID: 25432947

9

Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.

Matinella A, Lanzafame M, Bonometti MA, Gajofatto A, Concia E, Vento S, Monaco S, Ferrari S. Matinella A, et al. Among authors: gajofatto a. J Neurol. 2015 May;262(5):1317-27. doi: 10.1007/s00415-015-7713-8. Epub 2015 Apr 1. J Neurol. 2015. PMID: 25877836

10

Brentuximab vedotin: axonal microtubule's Apollyon.

Mariotto S, Ferrari S, Sorio M, Benedetti F, Tridente G, Cavallaro T, Gajofatto A, Monaco S. Mariotto S, et al. Among authors: gajofatto a. Blood Cancer J. 2015 Aug 28;5(8):e343. doi: 10.1038/bcj.2015.72. Blood Cancer J. 2015. PMID: 26314985 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters